Xie Junhui, Li Zhen, Tang Yi
Department of Endocrinology Department of Radiology Department of Hemotology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Medicine (Baltimore). 2018 Jun;97(26):e11215. doi: 10.1097/MD.0000000000011215.
Langerhans cell histiocytosis (LCH) involving non-endocrine organs has been frequently reported, whereas LCH involving endocrine organs is rare and the mechanism is unclear.
We report a case of multiple-systemic Langerhans cell histiocytosis (LCH) that first manifested with thyroid goiter, followed by pituitary and liver involvement.
The diagnosis was confirmed based on immunohistochemistry of the thyroid and liver.
The patient was treated with thyroidectomy combined with chemotherapy and radiation therapy for thyroid and liver, respectively.
Surprisingly, the patient presented with clinical remission and no new lesion of LCH was found during follow-up over 10 years.
LCH involving the endocrine system is unusual and easily misdiagnosed or delayed, especially when the thyroid and pituitary glands are involved. Pathological examination is necessary for a definitive diagnosis. Regular examinations, such as anterior and posterior pituitary hormones, should be especially evaluated annually in the patients with LCH involving endocrine system.
朗格汉斯细胞组织细胞增多症(LCH)累及非内分泌器官的情况已有频繁报道,而累及内分泌器官的LCH则较为罕见,其机制尚不清楚。
我们报告一例多系统朗格汉斯细胞组织细胞增多症(LCH),最初表现为甲状腺肿大,随后累及垂体和肝脏。
根据甲状腺和肝脏的免疫组织化学检查确诊。
患者接受了甲状腺切除术,并分别对甲状腺和肝脏进行了化疗和放疗。
令人惊讶的是,患者实现了临床缓解,在超过10年的随访中未发现LCH新病灶。
LCH累及内分泌系统较为罕见,容易误诊或延误诊断,尤其是当甲状腺和垂体受累时。明确诊断需要进行病理检查。对于累及内分泌系统的LCH患者,应每年特别评估垂体前后叶激素等常规检查。